HCA
UTMD icon

Harbor Capital Advisors’s Utah Medical Products UTMD Stock Holding History

Harbor Capital Advisors’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11K Buy
178
+148
+493% +$9.32K ﹤0.01% 963
2025
Q4 		$2K Sell
30
-1
-3% -$58 ﹤0.01% 1291
2025
Q3 		$2K Sell
31
-52
-63% -$3.08K ﹤0.01% 1310
2025
Q2 		$5K Sell
83
-6
-7% -$326 ﹤0.01% 1191
2025
Q1 		$5K Hold
89
– – ﹤0.01% 1215
2024
Q4 		$5K Sell
89
-2
-2% -$129 ﹤0.01% 1149
2024
Q3 		$6K Buy
+91
New +$6.18K ﹤0.01% 1109

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harbor Capital Advisors's UTMD Position: Q1 2026 in Review

Harbor Capital Advisors increased its Utah Medical Products (UTMD) stake by 493% in Q1 2026, buying an estimated $9.32K and bringing the position to 178 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #963.

Harbor Capital Advisors first reported a position in UTMD in Q3 2024 and has held it in 7 quarters since. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Harbor Capital Advisors held 178 shares of Utah Medical Products worth $11K as of Q1 2026.
  • Harbor Capital Advisors bought 148 Utah Medical Products shares in Q1 2026, an estimated $9.32K.
  • Utah Medical Products made up ﹤0.01% of Harbor Capital Advisors's portfolio in Q1 2026, its #963 holding.
  • Harbor Capital Advisors first reported a position in Utah Medical Products in Q3 2024 and has held it in 7 quarters since.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.